Brought to you by 
Advanced BioHealing buys wound care products from S&N
05 Dec 2022
Executive Summary
Advanced BioHealing (regenerative medicine) has acquired assets and rights from Smith & Nephew to the Dermagraft and TransCyte advanced wound healing products, which are both currently approved for marketing in the US and certain other countries.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
- Product Purchase
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Advanced BioHealing buys wound care products from S&N
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice